Atripla Prescribing Information
Download Full U.S. Prescribing Information, including BOXED WARNINGS
Adobe Acrobat Reader
Downloading files on this page requires the Adobe Acrobat Reader
|
|
Atripla® (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg)
| Study Number |
Study Title |
Study Summary |
| GS-US-177-0107 |
Phase IV, Open-label, Randomized, Multicenter Study Evaluating Efficacy and Tolerability of Single Tablet Regimen of Efavirenz/Emtricitabine/Tenofovir DF Compared to Unmodified HAART in HIV-1 Infected Subjects Who Have Achieved Virological Suppression on their HAART Regimen. |
Download Study Summary |
|
